VideosView all on youtube
Breast Cancer Group News Press release
PRESS RELEASE: 1 out of 3 men with breast cancer does not receive adequate treatment
European and Japanese Clinical Research Organisations Meet to Collaborate on Future Studies in Cancer.
Foundation Medicine and European Organisation for Research and Treatment of Cancer (EORTC) Announce Collaboration to Advance Precision Medicine Using Comprehensive Genomic Profiling to Facilitate Clinical Trial Enrollment
Melanoma Group News
Merck’s KEYTRUDA® (pembrolizumab) Significantly Improved Recurrence-Free Survival Compared to Placebo as Adjuvant Therapy in Patients with Stage 3 Resected High-Risk Melanoma (EORTC1325/KEYNOTE-054)